Last Price Today's Change   Day's Range   Trading Volume
13.66   0.00 (0.00%)  13.66 - 13.72  22,300


Board:Main Market
Avg Volume (4 weeks):64,573
4 Weeks Range:13.12 - 13.86
52 Weeks Range:13.12 - 18.80
Average Price Target:14.64
Price Target Upside/Downside:+0.98
View Price Target Detail

Business Background

The Gabelli Equity Trust Inc. (the Equity Trust) is a non-diversified, closed-end management investment company. The Company's primary objective is long-term growth of capital. The Equity Trust will invest at least 80% of its assets in equity securities. The 80% Policy may be changed without shareholder approval. It may purchase or write call or put options on securities or indices. It may invest up to 10% of its net assets in securities, for which the markets are illiquid. The Fund invests in various sectors, including food and beverage, financial services, cable and satellite, energy and utilities, diversified industrial, telecommunications, entertainment, consumer products, healthcare, retail, machinery and business. The Company's investment advisor is Gabelli Funds, LLC.

  Be the first to like this.
logitrader insider started to buy - http://www.klse.my/stock/insider/substantialShareholder/all/3255.jsp#stockDetailDiv

a sign of recover?
10/07/2014 17:36
PeterNg Wait.
11/07/2014 11:11
TradeInvestStocks Sleeping beauty slowly waking up???
11/07/2014 16:38
TradeInvestStocks Slowly waking up??? hahaha
14/07/2014 11:38
TradeInvestStocks Starting to move... waiting...
14/07/2014 16:25
TradeInvestStocks Up 32 sen just not too bad for today...
14/07/2014 16:55
angkor Uptrend started... after world cup effect
14/07/2014 20:17
mikashearer Uptrend after foreign buyer coming
15/07/2014 23:25
johnny cash Higher A&P expenses to boost
sales volume
In light of weaker consumer spending and saturating alcohol
consumption in the country, we foresee a tough operating environment
for GAB. Its aggressive launch of new products will have minimal
impact on its bottomline as product launches entail A&P spending.

Weak demand, higher operating costs,
saturating consumption levels and the
higher incidence of contraband add
up to a tough operating environment
for GAB. Its dividend yield of
4.4-4.7% seems low for the risks taken.
We maintain our Reduce call while
lowering our DCF-based target price
as we increase our beta assumption to
be more in line with its beta. Switch to
F&B or REITs for yields.
Poor consumption and higher
A&P cost hit 3Q
GAB performed worse than Carlsberg
in the quarter ending Mar, with
revenue dropping by 15.8% and net
profit plunging by 41.9% yoy due to
weak consumption and high
advertising and promotion expenses.
Despite the environment of weaker
consumption, GAB will continue to
invest in A&P in the hope that each
dollar spent will translate into better
sales volume.
More new products in the
GAB has launched two new super
premium products in the past few
months – Kirin Beer in Mar/Apr and
Sminoff in Jun. Apart from these new
products, we understand that GAB
plans to roll out two more new
products in the premium segment in
FY15. A&P expenses are expected to
remain high in FY15 due to the
committed new launches.
4Q results will remain weak
GAB’s 4QFY6/14 results could be
weaker yoy due to poor consumption
and high A&P expenses. While the
company is launching premium
products aggressively, new products
take time to gain recognition and their
impact on the bottomline will be
minimal for now. Furthermore,
Carlsberg which has a larger premium
product portfolio is stronger in the
premium segment.
22/07/2014 08:07
TradeInvestStocks getting better & better...
22/07/2014 18:01


445  327  409  470 

Top 10 Active Counters
 MAS 0.225-0.005 
 SUMATEC 0.410.00 
 TALAMT 0.120.00 
 SASBADI 1.49+0.30 
 AAX 0.83+0.015 
 NEXGRAM 0.1150.00 
 SONA-WA 0.285+0.005 
 PRIVA 0.16+0.01 
 IFCAMSC-WA 0.175+0.005 
 ECONBHD 0.875+0.055 


2. Maybank Research Highlights - 22 July 2014 KL Trader Investment Research Articles
3. AIRASIA - All eyes on MAS’ restructuring AmResearch
4. AAX: The real deal? Nexttrade
5. SHL CONSOLIDATED - Untapped Value PublicInvest Research
Partners & Brokers